TGFB1 and inflammatory bowel disease: Recently, the same group [31] found that EVs with high levels of TGF-β1 were released from intestinal epithelial cells under physiological conditions and contribute to maintain intestinal tract immunotolerance, since the transfer of these EVs into inflammatory bowel disease mice decreases disease severity by promoting development of Tregs and immunosuppressive DCs.